Should you microdose Ozempic? Experts are split on risks vs benefits

The emergence of GLP-1s (glucagon-like peptide-1 receptor agonists) has introduced caller approaches to some value nonaccomplishment and wide metabolic health.

Some users person recovered that microdosing, oregon taking the cause successful tiny amounts, achieves the champion wellness outcomes, but immoderate experts pass against it.

In a erstwhile interrogation with Fox News Digital, Dr. Terry Dubrow, a integrative surgeon and TV property based successful Newport Beach, California, recommended that everyone takes a debased regular dose, adjacent if they don’t request to suffer weight.

DOCTOR REVEALS SECRETS TO LASTING WEIGHT LOSS WITHOUT COUNTING CALORIES

"I americium obsessed with the conception of microdosing," helium said. "I deliberation possibly fractional the starting dose for diabetes is the mode to spell — and you astir apt don't request it each 7 days, it's astir apt each 10 days, conscionable to benignant of modulate the magnitude of sweetener successful the blood."

Microdosing GLP-1s could beryllium much costly long-term, according to a bariatric surgeon. (iStock)

The attack has gained popularity connected societal media, arsenic influencers and self-proclaimed "health gurus" person promoted it adjacent for radical without diabetes oregon obesity.

In a caller occurrence of the Full Send podcast, Bryan Johnson, a task capitalist and online creator who aims to reverse aging and widen quality lifespan, shared that helium microdoses Ozempic.

WHY MICRODOSING OZEMPIC COULD BECOME AS COMMON AS TAKING A MULTIVITAMIN

"There are immoderate broadside effects. For example, the dose I'm connected raises my resting bosom complaint by 2 oregon 3 beats, which is simply a large woody for me, but the benefits are great," helium said.

"GLP-1s are the archetypal legit longevity drug," helium went on. "It’s an astonishing cause … There’s conscionable thing that rivals its efficacy."

"It’s an astonishing cause … There’s conscionable thing that rivals its efficacy," Bryan Johnson said astir Ozempic. (iStock)

Johnson suggested that a aboriginal wherever astir radical are microdosing GLP-1s is "not excessively acold off."

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

"I americium arsenic steadfast arsenic a idiosyncratic tin be, and I inactive payment from GLP-1s," helium said. "It has different metabolic effects, it has bully neuroprotective effects."

Despite these claims, immoderate weight-loss experts find this attack to beryllium not lone much costly, but besides little effective.

One longevity guru suggested that a aboriginal wherever astir radical are microdosing a GLP-1s is "not excessively acold off." (REUTERS/Hollie Adams/File Photo)

Dr. Andre Teixeira, a bariatric surgeon with the Orlando Health Weight Loss and Bariatric Surgery Institute, told Fox News Digital that microdosing is "truly dependent" connected the individual.

CLICK HERE FOR MORE HEALTH STORIES

"The interest is determination is nary existent protocol for it," helium said. "We bash not bash microdosing astatine our practice."

While immoderate radical whitethorn deliberation microdosing is cheaper, the doc claims it tin beryllium "more costly successful the agelong run."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"[That's] due to the fact that you’re adjusting the dose and past not getting the afloat benefits of the medication," helium said. "I spot radical who get frustrated that they are not achieving the weight-loss extremity they were hoping for due to the fact that they are spreading retired their doses."

"The hazard is that you’re not lone playing with the imaginable benefits, but you’re besides playing with the broadside effects, similar nausea and vomiting."

The adept recommends moving intimately with a healthcare supplier earlier starting a GLP-1. "I bash not promote microdosing connected your own," helium added.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Fox News Digital reached retired to GLP-1 drugmakers Novo Nordisk and Lilly for comment. 

Fox News Digital's Melissa Rudy contributed to this report.